TCIM
EIDX

TIAA CREF Investment Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

TIAA CREF Investment Management’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		$715K Buy
+30,472
New +$715K ﹤0.01% 2459